** Shares of Genscript Biotech Corp 1548.HK jump 8.3% to HK$17.78, their highest since June 11
** Stock on course for the biggest one-day pct gain since June 9; fifth biggest pct gainer on healthcare index .HSCIH, which is up 0.5%
** The bioscience research group expects its H1 profit before tax to be in $175.4 mln-$204.6 mln range, as compared to $127.9 mln loss the same period a year ago, thanks to an increase in license revenue among others
** Hang Seng Biotech Index .HSHKBIO climbs 0.7%, Hang Seng Index .HSI gains 0.3%
** YTD, stock up 74.8%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。